H.B. Fuller (NYSE:FUL) Issues Earnings Results, Beats Estimates By $0.01 EPS

H.B. Fuller (NYSE:FULGet Rating) posted its quarterly earnings results on Wednesday. The specialty chemicals company reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.01, Briefing.com reports. H.B. Fuller had a return on equity of 13.80% and a net margin of 5.33%. The company had revenue of $941.20 million for the quarter, compared to analysts’ expectations of $944.11 million. During the same period in the previous year, the firm earned $0.79 EPS. The firm’s revenue was up 13.8% compared to the same quarter last year.

H.B. Fuller Stock Performance

Shares of H.B. Fuller stock opened at $61.66 on Friday. The stock’s fifty day moving average is $64.78 and its two-hundred day moving average is $65.69. The company has a market capitalization of $3.28 billion, a PE ratio of 17.27 and a beta of 1.54. The company has a quick ratio of 1.20, a current ratio of 1.95 and a debt-to-equity ratio of 1.18. H.B. Fuller has a 52 week low of $57.36 and a 52 week high of $81.73.

H.B. Fuller Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, July 28th. Shareholders of record on Thursday, July 14th were given a $0.19 dividend. This represents a $0.76 annualized dividend and a yield of 1.23%. The ex-dividend date of this dividend was Wednesday, July 13th. H.B. Fuller’s dividend payout ratio (DPR) is presently 21.29%.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. Deutsche Bank Aktiengesellschaft reduced their price objective on H.B. Fuller from $85.00 to $72.00 and set a “buy” rating on the stock in a research note on Friday, June 24th. JPMorgan Chase & Co. downgraded H.B. Fuller from a “neutral” rating to an “underweight” rating and cut their target price for the company from $70.00 to $52.00 in a research report on Friday, June 24th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $71.00.

Insiders Place Their Bets

In other news, Director Trangsrud Teresa J. Rasmussen bought 1,000 shares of the stock in a transaction on Tuesday, July 5th. The stock was acquired at an average cost of $58.20 per share, for a total transaction of $58,200.00. Following the acquisition, the director now owns 1,000 shares of the company’s stock, valued at $58,200. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, VP Nathan D. Weaver sold 5,326 shares of the company’s stock in a transaction on Thursday, August 11th. The stock was sold at an average price of $66.91, for a total transaction of $356,362.66. Following the completion of the sale, the vice president now directly owns 3,354 shares in the company, valued at approximately $224,416.14. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Trangsrud Teresa J. Rasmussen acquired 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, July 5th. The shares were bought at an average price of $58.20 per share, with a total value of $58,200.00. Following the completion of the purchase, the director now directly owns 1,000 shares in the company, valued at $58,200. The disclosure for this purchase can be found here. Company insiders own 4.69% of the company’s stock.

Institutional Investors Weigh In On H.B. Fuller

Hedge funds have recently made changes to their positions in the stock. UBS Asset Management Americas Inc. lifted its stake in shares of H.B. Fuller by 4.9% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 66,538 shares of the specialty chemicals company’s stock worth $4,006,000 after purchasing an additional 3,081 shares during the last quarter. Luminus Management LLC acquired a new position in H.B. Fuller during the 1st quarter valued at about $3,396,000. MetLife Investment Management LLC increased its position in H.B. Fuller by 55.7% during the 1st quarter. MetLife Investment Management LLC now owns 27,833 shares of the specialty chemicals company’s stock valued at $1,839,000 after buying an additional 9,960 shares in the last quarter. Finally, Eagle Bay Advisors LLC acquired a new position in H.B. Fuller during the 2nd quarter valued at about $33,000. 96.38% of the stock is currently owned by hedge funds and other institutional investors.

About H.B. Fuller

(Get Rating)

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products worldwide. The company operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.

Read More

Earnings History for H.B. Fuller (NYSE:FUL)

Receive News & Ratings for H.B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H.B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.